ASX:MYX

Email Alerts for:
ASX:MYX

July stocks in review

09 Aug 2017 - Sequoia Wealth Management, CEO Hamish McCathie reviews his stock picks for July and evaluates their performance over the month.

In reverse: Aus shares 0.78% lower at noon

08 Aug 2017 - In reverse: Aus shares 0.78% lower at noon. Mayne Pharma Group Limited (ASX:MYX) has provided an update on its expected FY17 results to the market.

API, BKL, MYX and a look at Telstra

26 Jul 2017 - Sequoia Wealth Management, CEO Hamish McCathie takes a look at Telstra Corporation, Australian Pharmaceutical Industries, Blackmores and Mayne Pharma Group.

Poor performance: Aus shares close 1.21% lower

15 Jun 2017 - Poor performance: Aus shares close 1.21% lower. Pilbara Minerals Limited (ASX:PLS) has announced an equity raising to develop its 100 per cent owned Pilgangoora Lith…

Mayne Pharma receives FDA approval & launches acne product in US

15 Jun 2017 - Mayne Pharma Group Limited (ASX:MYX) receives US Food and Drug Administration approval for its generic version of Acticlate tablets, for the treatment of infections, …

Mayne Pharma acquires US rights to generic Duragesic patch

09 Mar 2017 - Mayne Pharma (ASX:MYX) adds generic Duragesic patches to its US product portfolio.

In the black: Aus shares close 0.19% higher

11 Jan 2016 - In the black: Aus shares close 0.19% higher. Bellamy’s Australia (ASX:BAL) shares tumble following an updated earnings outlook and board shake up.

Mayne Pharma rolls out dermatology products in US

11 Jan 2017 - Mayne Pharma Group Limited (ASX:MYX) begins promoting two dermatology products in the United States, under its specialty franchise brand, Doryx.

Out of puff: Aus shares close 0.1% lower

16 Dec 2016 - Out of puff: Aus shares close 0.1% lower. Mayne Pharma Group Limited (ASX:MYX) says multiple US states have commenced legal proceedings against the company in the Uni…

Post-US election still going strong: ASX to open higher

07 Dec 2016 - Post-US election still going strong: ASX to open higher. H2-Pharma acquires the exclusive rights to distribute fifteen products from Mayne Pharma Group (ASX:MYX).

Friday falls: Aus shares 0.63% lower at noon

04 Nov 2016 - Friday falls: Aus shares 0.63% lower at noon. Mayne Pharma Group Limited (ASX:MYX) continues to assure its investors it's cooperating with the US Department of Justi…

Flat finish: Aus shares close 0.07% lower

03 Nov 2016 - Flat finish: Aus shares close 0.07% lower. Adairs Limited (ASX:ADH) says trading for the first four months of this financial year has been below company expectations…

Mayne Pharma to sell generic brand morphine meds in US

03 Nov 2016 - Mayne Pharma Group Ltd (ASX:MYX) receives US FDA approval to launch a generic brand medication, containing morphine, which will be used to manage severe pain.

Flat-lining Friday: Aus shares close 0.1% higher

29 Jul 2016 - Flat-lining Friday: Aus shares close 0.1% higher. Megaport Limited (ASX:MP1) has announced it has successfully completed a private placement of 10.5 million shares t…

Mayne Pharma Group settles patent infringement case

29 Jul 2016 - Mayne Pharma Group Limited (ASX:MYX) has announced it has entered into a settlement agreement with Forest Laboratories.

Market Wrap: Markets close 0.2% higher

07 Jun 2016 - It was a strong start to trading, with the Australian share market hitting high of 5,390 points at midday. Charter Hall Group (ASX:CHC) is preparing to list a new r…

Mayne Pharma to sell new heart disease meds in US

07 Jun 2016 - Mayne Pharma Group Limited (ASX:MYX) granted FDA approval for dofetlide sales.

Mayne profit slips on acquisition costs

28 Aug 2015 - Mayne Pharma Group Limited (ASX:MYX) reports a lower net profit for FY15 with the underlying figure coming down 25% to $13.4M.

Outlook: Aus shares set for a soft start

26 Jun 2015 - Aus shares set for a soft start. Mayne Pharma Group Limited (ASX:MYX) announce a successful US$125 million debt refinancing.

Mayne regains controls of Oxycodone

04 May 2015 - Mayne Pharma Group Limited (ASX:MYX) it has ended a distribution agreement with Mylan.

Market Wrap: Aus shares down for second day

10 Feb 2015 - Aus shares down for second day. Slater and Gordon Limited (ASX:SGH) produced a 37.6 per cent jump in first half revenue raising net profit by 46.5 per cent

Mayne expands US business

10 Feb 2015 - Mayne Pharma Group Limited (ASX:MYX) have announces new US acquisitiosn and a capital raising .

Identifying stocks with growth prospects

06 Nov 2014 - Fairview Equity Partners Executive Director & Portfolio Manager Chris Adams outlines how the fund identifies stocks with growth prospects.

Identifying health care stocks with superior returns

04 Aug 2014 - Fairview Equity Partners, Portfolio Manager Michael Glenane outlines how the fund discovers opportunities in the small healthcare space.

When will the bubble burst?

02 Apr 2014 - Investment advisor Gary Glover takes a technical look at S&P/ASX200, S&P 500, S&P/ASX Financials, Nasdaq, WBC, ANZ, QAN, TRS, MYX, CWN.